AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Geriatr Psychiatry 15:435-437, May 2007
© 2007 American Association for Geriatric Psychiatry
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharp, S. I.
Right arrow Articles by Francis, P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharp, S. I.
Right arrow Articles by Francis, P. T.

Brief Report

Aggressive Behavior and Neuroleptic Medication Are Associated With Increased Number of Alpha1-Adrenoceptors in Patients With Alzheimer Disease

Sally I. Sharp, B.Sc., Clive G. Ballard, M.R.C.Psych., Christopher P. L.-H. Chen, M.R.C.P., and Paul T. Francis, Ph.D.

From King’s College London (SIS, CGB, PTF), Wolfson Centre for Age-Related Diseases, London, U.K.; and the Department of Neurology (CPL-HC), National Neuroscience Institute, Singapore.

Objective: Aggressive behavior in dementia is a major clinical management problem.

Method: Postmortem brain tissue was obtained from 24 patients with Alzheimer disease (AD) and 25 comparison cases. [3H] Prazosin binding to {alpha}1-AdR was determined.

Results: Aggressive behavior was significantly correlated with {alpha}1-adrenoceptor number in patients with AD (Rs=0.454, N=24). Furthermore, patients receiving ongoing neuroleptics had significantly higher Bmax for [3H] prazosin (21 ± 2, N=9) than those who were not (16 ± 1, N=15).

Conclusions: Upregulation of {alpha}1-AdR is associated with aggressive behavior and chronic treatment with neuroleptic medication.

Key Words: Alzheimer disease • neuroleptics • alpha-1 adrenoceptors




This article has been cited by other articles:


Home page
AJGPHome page
C. Lyketsos
Apathy and Agitation: Challenges and Future Directions
Am J Geriatr Psychiatry, May 1, 2007; 15(5): 361 - 364.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2007 American Association for Geriatric Psychiatry